chr20-58903792-G-A
Position:
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_000516.7(GNAS):c.432+1G>A variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: not found (cov: 31)
Consequence
GNAS
NM_000516.7 splice_donor, intron
NM_000516.7 splice_donor, intron
Scores
5
1
1
Splicing: ADA: 1.000
2
Clinical Significance
Conservation
PhyloP100: 9.40
Genes affected
GNAS (HGNC:4392): (GNAS complex locus) This locus has a highly complex imprinted expression pattern. It gives rise to maternally, paternally, and biallelically expressed transcripts that are derived from four alternative promoters and 5' exons. Some transcripts contain a differentially methylated region (DMR) at their 5' exons, and this DMR is commonly found in imprinted genes and correlates with transcript expression. An antisense transcript is produced from an overlapping locus on the opposite strand. One of the transcripts produced from this locus, and the antisense transcript, are paternally expressed noncoding RNAs, and may regulate imprinting in this region. In addition, one of the transcripts contains a second overlapping ORF, which encodes a structurally unrelated protein - Alex. Alternative splicing of downstream exons is also observed, which results in different forms of the stimulatory G-protein alpha subunit, a key element of the classical signal transduction pathway linking receptor-ligand interactions with the activation of adenylyl cyclase and a variety of cellular reponses. Multiple transcript variants encoding different isoforms have been found for this gene. Mutations in this gene result in pseudohypoparathyroidism type 1a, pseudohypoparathyroidism type 1b, Albright hereditary osteodystrophy, pseudopseudohypoparathyroidism, McCune-Albright syndrome, progressive osseus heteroplasia, polyostotic fibrous dysplasia of bone, and some pituitary tumors. [provided by RefSeq, Aug 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PVS1
Splicing +-2 bp (donor or acceptor) variant, product NOT destroyed by NMD, known LOF gene, truncates exone, which is 0.10042194 fraction of the gene. No cryptic splice site detected. Exon removal is inframe change.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 20-58903792-G-A is Pathogenic according to our data. Variant chr20-58903792-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 446491.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-58903792-G-A is described in Lovd as [Pathogenic]. Variant chr20-58903792-G-A is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GNAS | NM_000516.7 | c.432+1G>A | splice_donor_variant, intron_variant | ENST00000371085.8 | NP_000507.1 | |||
GNAS | NM_016592.5 | c.*338+1G>A | splice_donor_variant, intron_variant | ENST00000371075.7 | NP_057676.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GNAS | ENST00000371085.8 | c.432+1G>A | splice_donor_variant, intron_variant | 1 | NM_000516.7 | ENSP00000360126.3 | ||||
GNAS | ENST00000371075.7 | c.*338+1G>A | splice_donor_variant, intron_variant | 1 | NM_016592.5 | ENSP00000360115.3 | ||||
GNAS | ENST00000676826.2 | c.2364+1G>A | splice_donor_variant, intron_variant | ENSP00000504675.2 | ||||||
GNAS | ENST00000371102.8 | c.2319+1G>A | splice_donor_variant, intron_variant | 5 | ENSP00000360143.4 | |||||
GNAS | ENST00000354359.12 | c.435+1G>A | splice_donor_variant, intron_variant | 1 | ENSP00000346328.7 | |||||
GNAS | ENST00000371095.7 | c.390+1G>A | splice_donor_variant, intron_variant | 1 | ENSP00000360136.3 | |||||
GNAS | ENST00000470512.6 | c.258+1G>A | splice_donor_variant, intron_variant | 5 | ENSP00000499552.2 | |||||
GNAS | ENST00000480232.6 | c.258+1G>A | splice_donor_variant, intron_variant | 5 | ENSP00000499545.2 | |||||
GNAS | ENST00000663479.2 | c.258+1G>A | splice_donor_variant, intron_variant | ENSP00000499353.2 | ||||||
GNAS | ENST00000462499.6 | c.213+1G>A | splice_donor_variant, intron_variant | 2 | ENSP00000499758.2 | |||||
GNAS | ENST00000467227.6 | c.213+1G>A | splice_donor_variant, intron_variant | 3 | ENSP00000499681.2 | |||||
GNAS | ENST00000478585.6 | c.213+1G>A | splice_donor_variant, intron_variant | 2 | ENSP00000499762.2 | |||||
GNAS | ENST00000481039.6 | c.213+1G>A | splice_donor_variant, intron_variant | 5 | ENSP00000499767.2 | |||||
GNAS | ENST00000485673.6 | c.213+1G>A | splice_donor_variant, intron_variant | 5 | ENSP00000499334.2 | |||||
GNAS | ENST00000488546.6 | c.213+1G>A | splice_donor_variant, intron_variant | 5 | ENSP00000499332.2 | |||||
GNAS | ENST00000492907.6 | c.213+1G>A | splice_donor_variant, intron_variant | 3 | ENSP00000499443.2 | |||||
GNAS | ENST00000453292.7 | c.*293+1G>A | splice_donor_variant, intron_variant | 5 | ENSP00000392000.2 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 genomes
Cov.:
31
GnomAD4 exome Cov.: 34
GnomAD4 exome
Cov.:
34
GnomAD4 genome Cov.: 31
GnomAD4 genome
Cov.:
31
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:5Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Pseudopseudohypoparathyroidism Pathogenic:2Other:1
not provided, no classification provided | literature only | GeneReviews | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego | Dec 20, 2017 | The c.2361+1G>A splice-site variant affects the canonical splice donor site of intron 5 and is thus predicted to be a loss of function mutation. It has been reported as a de novo heterozygous change in a patient with pseudopseudohypoparathyroidism (Wilson et al, 1997) and is absent from the ExAC and gnomAD population databases. Sanger sequencing of the parental samples was negative for the variant indicating that this variant likely represents a de novo change in the patient. However, low level parental mosaicism cannot be excluded. Based on the combined evidence, c.2361+1G>A is classified as a pathogenic variant. - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | May 08, 2023 | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 09, 2020 | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. This variant has been observed in individual(s) with pseudopseudohypoparathyroidism (PMID: 7853365). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 446491). This variant is not present in population databases (ExAC no frequency). This sequence change affects a donor splice site in intron 5 of the GNAS gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in GNAS are known to be pathogenic (PMID: 11784876, 23281139, 23796510, 25802881). - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 01, 2023 | Canonical splice site variant predicted to result in an in-frame loss of the adjacent exon in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 29072892, 23281139, 25525159, 23884777, 31624069, 30577886, 31019026, 31886927, 25802881, 7853365, 35296306) - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 29, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
dbscSNV1_RF
Pathogenic
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DG_spliceai
Position offset: -36
DS_DL_spliceai
Position offset: -1
Find out detailed SpliceAI scores and Pangolin per-transcript scores at